Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ASCO on gene testing

This article was originally published in The Gray Sheet

Executive Summary

In an updated policy statement on genetic screening released Jan. 11, the American Society of Clinical Oncology says it now believes there is wiggle room in whether or not it is reasonable to perform genetic testing on a patient without family history of cancer. Oncologists should still consider ASCO's 2003 guidance to offer genetic testing to a patient based on the criteria that the patient has a history suggestive of cancer susceptibility, that the genetic test can be "adequately" interpreted and that the results have accepted clinical utility, but now says that the first point may not always be crucial with emerging genomic screening technologies. ASCO also pushes for increased oversight of genetic testing by both FDA and CMS, and proclaims its support for a publicly available registry that requires manufacturers of genetic tests to disclose information about their tests' analytical and clinical validity, as well as clinical utility
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT028394

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel